ATE478947T1 - Kontinuierliche in vitro-evolution. - Google Patents

Kontinuierliche in vitro-evolution.

Info

Publication number
ATE478947T1
ATE478947T1 AT99918964T AT99918964T ATE478947T1 AT E478947 T1 ATE478947 T1 AT E478947T1 AT 99918964 T AT99918964 T AT 99918964T AT 99918964 T AT99918964 T AT 99918964T AT E478947 T1 ATE478947 T1 AT E478947T1
Authority
AT
Austria
Prior art keywords
mutant
mrna
population
protein
rna
Prior art date
Application number
AT99918964T
Other languages
English (en)
Inventor
Gregory Coia
Peter Hudson
Peter Iliades
Robert Irving
Original Assignee
Diatech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatech Pty Ltd filed Critical Diatech Pty Ltd
Application granted granted Critical
Publication of ATE478947T1 publication Critical patent/ATE478947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1041—Ribosome/Polysome display, e.g. SPERT, ARM
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT99918964T 1998-05-08 1999-05-07 Kontinuierliche in vitro-evolution. ATE478947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP3445A AUPP344598A0 (en) 1998-05-08 1998-05-08 Continuous one step in-vitro evolution
PCT/AU1999/000341 WO1999058661A1 (en) 1998-05-08 1999-05-07 Continuous in vitro evolution

Publications (1)

Publication Number Publication Date
ATE478947T1 true ATE478947T1 (de) 2010-09-15

Family

ID=3807699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99918964T ATE478947T1 (de) 1998-05-08 1999-05-07 Kontinuierliche in vitro-evolution.

Country Status (9)

Country Link
US (1) US6562622B1 (de)
EP (1) EP1075513B8 (de)
JP (2) JP4519318B2 (de)
AT (1) ATE478947T1 (de)
AU (1) AUPP344598A0 (de)
CA (1) CA2328515C (de)
DE (1) DE69942701D1 (de)
ES (1) ES2351275T3 (de)
WO (1) WO1999058661A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170820A1 (en) * 1998-05-08 2003-09-11 Gregory Coia Continuous in- vitro evolution
US7153655B2 (en) 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
EP1092046A4 (de) * 1998-07-02 2003-02-19 Invitro Diagnostics Inc Verfahren, zusammensetzngen und apparat zur herstellung von nukleinsäuremolekülen mit selektiver affinität für ein zielmolekül
JP2003519495A (ja) 2000-01-11 2003-06-24 マキシジェン， インコーポレイテッド 多様性生成およびスクリーニングのための一体化されたシステムおよび方法
EP1652919A1 (de) * 2000-03-31 2006-05-03 Cambridge Antibody Technology LTD Verbesserungen in Bezug auf Ribosom-Komplexe als Selektionspartikel
DK1268766T3 (da) 2000-03-31 2006-04-10 Cambridge Antibody Tech Forbedringer af ribosom-display
US6958213B2 (en) 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
EP1487969A4 (de) * 2001-12-07 2008-07-09 Dyax Corp Verfahren und vorrichtung zum waschen von magnetisch reagierenden teilchen
DE60312507T3 (de) 2002-05-17 2011-08-18 Alligator Bioscience Ab Eine methode zur in vitro molekularen evolution der proteinfunktion
US8557743B2 (en) 2002-09-05 2013-10-15 Dyax Corp. Display library process
CA2503890A1 (en) * 2002-11-01 2004-05-13 Evogenix Pty Ltd Mutagenesis methods using ribavirin and/or rna replicases
ATE544781T1 (de) 2004-12-13 2012-02-15 Cephalon Australia Vic Pty Ltd Osteoprotegerinvarianten-proteine
DE102005037349A1 (de) * 2005-08-08 2007-02-15 Geneart Ag Verfahren für die kontinuierliche zielgerichtete Evolution von Proteinen in vivo
US7879975B2 (en) * 2006-06-29 2011-02-01 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7777002B2 (en) * 2006-06-29 2010-08-17 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7993873B2 (en) * 2006-06-29 2011-08-09 The Invention Science Fund I, Llc Apparatus for arbitrary peptide synthesis
US7910695B2 (en) * 2006-06-29 2011-03-22 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7923533B2 (en) * 2006-06-29 2011-04-12 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US20100184959A1 (en) * 2007-03-19 2010-07-22 Medimmune Limited Polypeptide Variants
CN101458255B (zh) * 2007-12-14 2013-03-06 武汉大学 丙型肝炎病毒包膜抗原夹心法试剂盒及检测方法
US9127057B2 (en) 2010-07-20 2015-09-08 Teva Pharmaceuticals Ausralia Pty Ltd Anti-IL-23 heterodimer specific antibodies
CN104114577A (zh) 2011-09-30 2014-10-22 特瓦制药澳大利亚私人有限公司 针对TL1a的抗体及其用途
NZ711543A (en) 2013-02-01 2020-08-28 Univ California Anti-cd83 antibodies and use thereof
WO2014121325A1 (en) 2013-02-07 2014-08-14 Csl Limited Il-11r binding proteins and uses thereof
EP3209695A4 (de) 2014-10-23 2018-05-30 DendroCyte BioTech Pty Ltd Cd83-bindende proteine und verwendungen davon
US10940212B2 (en) 2014-12-19 2021-03-09 Monash University IL-21 agonist antibodies and methods of treatment using same
EP3380514A4 (de) 2015-11-27 2019-05-22 CSL Limited Gdf131-bindende proteine und verwendungen davon
CA3158174A1 (en) 2019-10-28 2021-05-06 Monash University Antibodies for binding plasmin
IL294045A (en) 2019-12-20 2022-08-01 Hudson Inst Med Res Proteins that bind to cxcl10 and their uses
WO2022260718A1 (en) * 2021-06-12 2022-12-15 Lin Shi Lung Novel replicase cycling reaction (rcr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786600A (en) 1984-05-25 1988-11-22 The Trustees Of Columbia University In The City Of New York Autocatalytic replication of recombinant RNA
DK0494955T3 (da) * 1989-10-05 1998-10-26 Optein Inc Cellefri syntese og isolering af hidtil ukendte gener og polypeptider
WO1994006928A1 (en) 1992-09-24 1994-03-31 The Public Health Research Institute Of The City Of New York, Inc. Coupled replication-translation methods and kits for protein synthesis

Also Published As

Publication number Publication date
EP1075513B8 (de) 2010-09-29
EP1075513B1 (de) 2010-08-25
JP2010119396A (ja) 2010-06-03
EP1075513A4 (de) 2003-07-16
WO1999058661A1 (en) 1999-11-18
EP1075513A1 (de) 2001-02-14
CA2328515C (en) 2011-10-18
JP4519318B2 (ja) 2010-08-04
US6562622B1 (en) 2003-05-13
ES2351275T3 (es) 2011-02-02
DE69942701D1 (de) 2010-10-07
CA2328515A1 (en) 1999-11-18
JP2002515224A (ja) 2002-05-28
AUPP344598A0 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
ATE478947T1 (de) Kontinuierliche in vitro-evolution.
Saks et al. The transfer RNA identity problem: a search for rules
Roberts et al. RNA-peptide fusions for the in vitro selection of peptides and proteins
He et al. Facile synthesis of site-specifically acetylated and methylated histone proteins: reagents for evaluation of the histone code hypothesis
Kraus PARPs and ADP-ribosylation: 50 years… and counting
Khaleghpour et al. Dual interactions of the translational repressor Paip2 with poly (A) binding protein
Morozov et al. A novel intermediate in transcription initiation by human mitochondrial RNA polymerase
Mears et al. A structural model for the large subunit of the mammalian mitochondrial ribosome
CY1115634T1 (el) Μεσα ανταγωνιστικης επιλεκτικης συνδεσης της πρωτεϊνης συνδεσης οστεοπροτεγερινης
US20120258871A1 (en) Peptide constructs and assay systems
ATE470712T1 (de) Nukleinsäureliganden mit hoher affinität zu dem c5-protein des komplementsystems
TW200519201A (en) Method for linking sequences of interest
Kar et al. Transcription of telomeric DNA leads to high levels of homologous recombination and t-loops
NO930011D0 (no) Tilfeldig boi-oligomer bibilotek og fremgangsmaate for syntese og anvendelse derav
van der Heden van Noort et al. Synthesis of mono-ADP-ribosylated oligopeptides using ribosylated amino acid building blocks
ATE211174T1 (de) Thymidin-kinase-mutanten
Chen et al. Incorporation of phosphorylated tyrosine into proteins: in vitro translation and study of phosphorylated IκB-α and its interaction with NF-κB
Zhu et al. Biomimetic α-selective ribosylation enables two-step modular synthesis of biologically important ADP-ribosylated peptides
Roberts et al. Loading of the nonhomologous end joining factor, Ku, on protein-occluded DNA ends
Mitchener et al. Janus bioparticles: asymmetric nucleosomes and their preparation using chemical biology approaches
DE69927249D1 (de) Induzierendes alphavirengen- expressionssystem
Palavicini et al. Extra double-stranded RNA binding domain (dsRBD) in a squid RNA editing enzyme confers resistance to high salt environment
Kamzeeva et al. 5′-UTR G-Quadruplex-Mediated Translation Regulation in Eukaryotes: Current Understanding and Methodological Challenges
Amikura et al. Multiple amino acid-excluded genetic codes for protein engineering using multiple sets of tRNA variants
Fukuda et al. Identification of an RNA element for specific coordination of A‐to‐I RNA editing on HTR 2C pre‐mRNA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties